欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0244/001
药品名称
SPIRAMYCINE CEVA
活性成分
spiramycin 600000.0 IU
剂型
Solution for injection
上市许可持有人
CEVA SANTE ANIMALE 10, AV DE LA BALLASTIERE 33500 LIBOURNE
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Portugal (PT)
Poland (PL)
Latvia (LV)
Spirovet
Lithuania (LT)
SPIROVET 600 000 TV/ml, injekcinis tirpalas galvijams ir kiaulėms
Estonia (EE)
Spirovet
Hungary (HU)
Bulgaria (BG)
Slovakia (SK)
Slovenia (SI)
许可日期
2012/06/27
最近更新日期
2024/06/10
药物ATC编码
QJ01FA02 spiramycin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
spiramycine 244 A 014 _labelling_leaflet_clean_014_track_day59 final
Date of last change:2024/09/06
Final SPC
|
Spiramycine 244 A 014_spc_clean_014_track_day59 final
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase